Chronic kidney disease (CKD) is a progressive condition characterized by the gradual loss of kidney function, which can ultimately lead to kidney failure or end-stage kidney disease (ESKD) if left untreated. Our ECM biomarkers reflect ongoing tissue remodeling and fibrosis, which are key processes driving CKD progression.
Learn more about how our biomarkers can help assess risk of kidney function decline or predict the risk of kidney-related outcomes and mortality.
We offer biomarkers in IgA nephropathy (IgAN) to detect early disease activity and predict progression more accurately beyond traditional markers. Our ECM biomarkers offer insights into fibrotic processes, enabling better patient stratification and early assessment of treatment response.
Get an overview of how our biomarkers for IgAN can provide such crucial value.
Diabetic kidney disease (DKD) is a major complication of diabetes and can lead to kidney failure.
Our ECM biomarkers can provide pharmacodynamic information that helps monitor treatment response and guide the development of more targeted therapies.
Here, you can get an overview of how our biomarkers can support DKD clinical trials.
Lupus nephritis (LN) is a complex autoimmune kidney disease characterized by inflammation and progressive fibrosis.
Our biomarkers capture key pathological processes and can support the development of more targeted and effective therapies, driving innovation in LN drug development.
Discover how our biomarkers for LN deliver critical insights that add value across drug development.
Nordic Bioscience effectively integrates innovative translational models with the Nordic ProteinFingerPrint™ Technology™ to translate findings efficiently. The use of the same biomarkers throughout various clinical development stages, including preclinical kidney models of fibrosis, create a seamless link between early research and clinical applications.
The ability to monitor fibroblast activity through ECM biomarkers further enhances the relevance of these models. This strategically chosen development pathway significantly boosts the efficiency of drug development pipelines.
Find more information about our translational models in kidney disease.
Nordic Bioscience’s assays and services are research use only products and services and do not qualify for medical or diagnostic purposes.
No upcoming events
